{"date":"2026-02-02","count":14,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6574-2026-02-02-1845-1njncgj","company_id":"6574","company":"霈方","market":"上櫃","industry":"生技醫療","date":"2026-02-02","time":"18:45:25","subject":"公告本公司最近一年累積取得有價證券達公告標準","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：霈方（6574），2026-02-02 18:45，「公告本公司最近一年累積取得有價證券達公告標準」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6841-2026-02-02-1758-1q4fc7q","company_id":"6841","company":"長佳智能","market":"上櫃","industry":"生技醫療","date":"2026-02-02","time":"17:58:32","subject":"本公司擬參與長聯科技股份有限公司預計辦理之現金增資案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長佳智能（6841），2026-02-02 17:58，「本公司擬參與長聯科技股份有限公司預計辦理之現金增資案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4173-2026-02-02-1734-9os4sv","company_id":"4173","company":"久裕","market":"上櫃","industry":"生技醫療","date":"2026-02-02","time":"17:34:37","subject":"公告本公司發言人暨代理發言人異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：久裕（4173），2026-02-02 17:34，「公告本公司發言人暨代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4173-2026-02-02-1733-i8tame","company_id":"4173","company":"久裕","market":"上櫃","industry":"生技醫療","date":"2026-02-02","time":"17:33:39","subject":"公告本公司董事會通過總經理任命案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：久裕（4173），2026-02-02 17:33，「公告本公司董事會通過總經理任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6815-2026-02-02-1624-lzscd5","company_id":"6815","company":"晶鑽生醫","market":"興櫃","industry":"生技醫療","date":"2026-02-02","time":"16:24:54","subject":"本公司受邀參加由富邦證券舉辦之法人說明會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晶鑽生醫（6815），2026-02-02 16:24，「本公司受邀參加由富邦證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4109-2026-02-02-1619-3sscqz","company_id":"4109","company":"加捷生醫","market":"上櫃","industry":"生技醫療","date":"2026-02-02","time":"16:19:52","subject":"本公司代子公司米香食品股份有限公司公告董事長及總經理異動","clause":"第6款","fact_date":"2026-02-02","cite_as":"公開資訊觀測站重大訊息：加捷生醫（4109），2026-02-02 16:19，「本公司代子公司米香食品股份有限公司公告董事長及總經理異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6841-2026-02-02-1605-1utl0ou","company_id":"6841","company":"長佳智能","market":"上櫃","industry":"生技醫療","date":"2026-02-02","time":"16:05:57","subject":"本公司董事會決議發行限制員工權利新股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長佳智能（6841），2026-02-02 16:05，「本公司董事會決議發行限制員工權利新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6892-2026-02-02-1530-1upq4ur","company_id":"6892","company":"台寶生醫","market":"興櫃","industry":"生技醫療","date":"2026-02-02","time":"15:30:46","subject":"公告本公司114年現金增資收足股款暨訂定增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台寶生醫（6892），2026-02-02 15:30，「公告本公司114年現金增資收足股款暨訂定增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6841-2026-02-02-1502-1hkzzd6","company_id":"6841","company":"長佳智能","market":"上櫃","industry":"生技醫療","date":"2026-02-02","time":"15:02:05","subject":"本公司董事會決議員工認股權憑證轉換普通股之增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長佳智能（6841），2026-02-02 15:02，「本公司董事會決議員工認股權憑證轉換普通股之增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6841-2026-02-02-1448-1hu3cbe","company_id":"6841","company":"長佳智能","market":"上櫃","industry":"生技醫療","date":"2026-02-02","time":"14:48:31","subject":"本公司董事會決議召開115年股東常會事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長佳智能（6841），2026-02-02 14:48，「本公司董事會決議召開115年股東常會事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4123-2026-02-02-1400-1xyvm86","company_id":"4123","company":"晟德","market":"上櫃","industry":"生技醫療","date":"2026-02-02","time":"14:00:27","subject":"公告本公司國內第七次無擔保轉換公司債於115年4月27日發行屆滿三年，債券持有人得行使賣回權相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晟德（4123），2026-02-02 14:00，「公告本公司國內第七次無擔保轉換公司債於115年4月27日發行屆滿三年，債券持有人得行使賣回權相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6491-2026-02-02-1051-1imsflw","company_id":"6491","company":"晶碩","market":"上市","industry":"生技醫療","date":"2026-02-02","time":"10:51:38","subject":"澄清115年1月31日新聞媒體報導","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晶碩（6491），2026-02-02 10:51，「澄清115年1月31日新聞媒體報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4142-2026-02-02-0949-1wu4t94","company_id":"4142","company":"國光生","market":"上市","industry":"生技醫療","date":"2026-02-02","time":"09:49:32","subject":"更正-公告本公司法人董事改派代表人","clause":"第6款","fact_date":"2026-02-02","cite_as":"公開資訊觀測站重大訊息：國光生（4142），2026-02-02 09:49，「更正-公告本公司法人董事改派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6885-2026-02-02-0006-1fpuvl9","company_id":"6885","company":"全福生技","market":"上市","industry":"生技醫療","date":"2026-02-02","time":"00:06:18","subject":"公告本公司開發中新藥BRM421治療乾眼症第II期劑量探索、安全性與療效性之人體臨床試驗完成首位受試者收案。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：全福生技（6885），2026-02-02 00:06，「公告本公司開發中新藥BRM421治療乾眼症第II期劑量探索、安全性與療效性之人體臨床試驗完成首位受試者收案。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}